The Royal Pharmaceutical Society (RPS) has warned about “patient safety” after discovering that draft HIV guidance directs ...

A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...

With new CDC data expressing optimism about the epidemic of sexually transmitted infections (STIs), take a look at the ...

Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...

Approved by the FDA 12 years ago, pre-exposure prophylaxis (PrEP) has significantly reduced the risk of HIV transmission and ...

Tengrinews.kz - A revolutionary HIV drug has been created: clinical trials have shown that its twice-yearly injections are 96 ...

In the context of World AIDS Day (December 1), the Pan American Health Organization (PAHO) has launched the “Better with PrEP ...

With Sunday marking the 37th annual World AIDS Day, the Michigan Department of Health and Human Services (DHHS) released its ...

In two mid-Michigan school districts where the HIV education curriculum was discovered to be out of date a year ago by 6 News ...

As medical scientists working in HIV prevention, we believe that HIV vaccines will be critical to eliminating HIV ...

President Joe Biden marks World AIDS Day with the AIDS Memorial Quilt at the White House, emphasizing support for those living with HIV.

Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...